Insiders · ETTX

John Patrick Mueller

Officer at Entasis Therapeutics Holdings Inc. (ETTX)

John Patrick Mueller has filed 5 insider reports with the SEC since January 2021, as officer at Entasis Therapeutics Holdings Inc. (ETTX). John Patrick Mueller made no open-market purchases or sales in the last 12 months. The latest filing, on July 11, 2022, reports sale back to the company, other acquisition or disposition and tender of shares in a change of control at Entasis Therapeutics Holdings Inc. (ETTX).

Filings
5
Companies
1
Bought on market
None
Sold on market
$12.8K

Companies where John Patrick Mueller is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Entasis Therapeutics Holdings Inc. logo
ETTX
Entasis Therapeutics Holdings Inc.
Officer0$12.8KJul 11, 2022

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare John Patrick Mueller with

Questions about John Patrick Mueller

What is John Patrick Mueller's role at Entasis Therapeutics Holdings Inc.?
John Patrick Mueller reports to the SEC as officer at Entasis Therapeutics Holdings Inc. (ETTX), according to the latest filing on July 11, 2022.
Has John Patrick Mueller bought or sold stock recently?
The most recent open-market sale was on October 19, 2021: sold 4,001 shares of Entasis Therapeutics Holdings Inc. (ETTX) for $12.8K at an average of $3.19.
How do I get alerts when John Patrick Mueller files?
Follow John Patrick Mueller on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by John Patrick Mueller (SEC CIK 0001751922). Totals count each trade once, skipping amendments whose original is on file, from Jan 19, 2021 on. View on SEC EDGAR · Get this as JSON